RE:NEW!! SIX buck target. Well, between Dougie LowBall Loe's prediction, the waning-right's $6 optimism, and Phil's uncontrolled smirking, I figure something's up. Only question is, who are they planning to throw under the bus this time 'round? If you picked up some extra play shares recently, in the mid seventies, you've done well.
stockhunter1 wrote: January 10-2023
Joseph Pantginis from H.C. Wainwright & Co. has done a fine job writing an analysis on Sernova. He is both a Ph.D and an M.S in Molecular Genetics and as such his evaluation was made with a very educated mind. His analysis was released the same day that Vertex's trial was put on hold. It makes me think our valuation may have been higher than $6 had Joseph been aware of the FDA decision to put a hold on Vertex's trial. Reports like this one and others are a culmination of many years of efforts and a testament to the future of Sernova. Enjoy the read and try to imagine the fair value of SVA (Patents,ETC) and the CELL pouch. 2023 will be a telling year. Do re-post this link as positive sentiment on all the bullboards will go along ways towards increasing our market cap before potential buyer'S step up.
https://hcwco.com/services/research/meet-our-analysts/#toggle-id-1